Company news
Cardiac Biotech Solutions Inc. news in 2017
Cardiac Biotech Solutions Inc.'s news releases, calls and decks from 2017, newest first.
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency
October 30, 2017
CB Scientific (CBSC) Secures the Intellectual Patent Rights for Pain-PatchTM, a Cannabinoid Pain Alleviation Technology
September 12, 2017
CB Scientific (CBSC) Completing the Prototyping of Pain-Patch -- a Major Breakthrough in Cannabinoid Pain Alleviation Technology
June 21, 2017
CB Scientific's (CBSC) CannaRAPID an Effective Intervention for Opioid Drug Addiction Patients -- Every Year Close to 28,000 People Die From an Opioid-Related Overdose in America
May 23, 2017
CB Scientific (CBSC) is Launching CannaRAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing -- Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption
May 15, 2017
CB Scientific (CBSC) Develops Cannabinoid Delivery Technologies: CannaRAPID(TM), CannaNASAL(TM) & CannaDERME(TM) for Precise & Controlled Release of Cannabinoid Compounds to Various Patient Groups
April 17, 2017
CB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device -- CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery
March 13, 2017
CB Scientific (CBSC) Pleased to Announce the Company is Current with OTC Markets
March 2, 2017